Menstrual cycle management: new concept for use of combined oral contraceptives
Abstract
Combined oral contraception is a safe and efficacious method of family planning. However, its clinical effectiveness is limited by problems with treatment adherence. These problems stem mainly from women s limited awareness about contraception mechanisms and possibilities it provides. This review outlines almost 4 decades of research on women s attitudes toward hormonal contraception, as well as interpretations of these data. It also provides evidence for the safety and effectiveness of extended oral contraception regimens, especially the ones utilizing electronic dispenser with alarm function. This method of contraception improves adherence and lets a woman to control her menstrual cycle, thus enhancing her self-regulation repertoire.
About the Authors
I. V. Kuznetsova
First Moscow State Medical University n.a. I. M. Sechenov
Russian Federation
Russian Federation
D. I. Burchakov
First Moscow State Medical University n.a. I. M. Sechenov
Russian Federation
Russian Federation
References
1. Denisov BP, Sakevich VI, Jasilioniene A. Divergent trends in abortion and birth control practices in belarus, Russia and Ukraine. PLoS One. 2012; 7 (11): e49986.
2. Thomas SL, Ellertson C. Nuisance or natural and healthy: should monthly menstruation be optional for women? Lancet (London, England). 2000 Mar 11; 355 (9207): 922-4.
3. Loudon NB, Foxwell M, Potts DM, Short R V, Guild AL, Short R V. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen. Br. Med. J. 1977 Aug 20; 2 (August): 487-90.
4. Cachrimanidou A, Hellberg D, Nilsson S, Waldenstrom U, Olsson S, Sikstrom B. Long-in-terval treatment regimen with a desogestrelcontaining oral contraceptive. Contraception. 1993; 48 (3): 205-16.
5. Archer DF, Jensen JT, Johnson J V, Borisute H, Grubb GS, Constantine GD. Evaluation of a continuous regimen of levonorgestrel/ ethinyl estradiol: phase 3 study results. Contraception. 2006 Dec; 74 (6): 439-45.
6. Sulak PJ, Scow RD, Preece C, Riggs MW, Kuehl TJ. Hormone withdrawal symptoms in oral contraceptive users. Obstet. Gynecol. 2000 Feb; 95 (2): 261-6.
7. Read CM. New regimens with combined oral contraceptive pills - moving away from traditional 21/7 cycles. Eur. J. Contracept. Reprod. Health Care. 2010 Dec; 15. Suppl2 (December): S32-41.
8. Benagiano G, Carrara S, Filippi V. Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ ethinylestradiol oral contraceptives. Patient Prefer. Adherence. 2009 Nov 3; 3: 131-43.
9. Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006 Aug; 108 (2): 428-41.
10. Schneider MB, Fisher M, Friedman SB, Bijur PE, Toffler AP. Menstrual and premenstrual issues in female military cadets: a unique population with significant concerns. J. Pediatr. Adolesc. Gynecol. 1999 Nov; 12 (4): 195-201.
11. Lee K, Zaffke ME, Baratte-Beebe K. Restless legs syndrome and sleep disturbance during pregnancy: the role of folate and iron. J. Womens Health Gend. Based Med. 2001; 10 (4): 335-41.
12. Szarewski A, von Stenglin A, Rybowski S. Women's attitudes towards monthly bleeding: results of a global population-based survey. Eur J Contracept Reprod Health Care. 2012 Aug; 17 (4): 270-83.
13. Andrist LC, Arias RD, Nucatola D, Kaunitz AM, Musselman BL, Reiter S, et al. Women’ s and providers' attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004 Nov; 70 (5): 359-63.
14. Wiegratz I, Hommel HH, Zimmermann T, Kuhl H. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004 Jan; 69 (1): 37-42.
15. Szarewski A, Moeller C. Women’s perceptions about reducing the frequency of monthly bleeding results from a multinational survey. Open Access J. Contracept. 2013; 4: 29-37.
16. Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004; 64 (21): 2447-62.
17. Ferrero S, Abbamonte LH, Giordano M, Alessandri F, Anserini P, Remorgida V, et al. What is the desired menstrual frequency of women without menstruation-related symptoms? Contraception. 2006 May; 73 (5): 537-41.
18. Glasier AF, Smith KB, van der Spuy ZM, Ho PC, Cheng L, Dada K, et al. Amenorrhea associated with contraception-an international study on acceptability. Contraception. 2003 Jan; 67 (1): 1-8.
19. Rutter W, Knight C, Vizzard J, Mira M, Abraham S. Women’s attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill. Med J Aust. 1988 Oct 17; 149 (8): 417-9.
20. den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999 Jun; 59 (6): 357-62.
21. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet. Gynecol. 2001 Nov; 98 (5 Pt 1): 771-8.
22. Edelman A, Micks E, Gallo MF, Jensen JT, Grimes DA. Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception. Cochrane database Syst. Rev. 2014; 7 (7).
23. Cintron D, Lipford M, Spencer-bonilla G, Lloyd R, Gionfriddo MR, Gunjal S, et al. Ef fi cacy of menopausal hormone therapy on sleep qualify: systematic review and meta-analysis. Endocrine. SpringerUS; 2016; 0-1. DO I: 10.1007/sl2020-016-1072-9.
24. Kwiecien M, Edelman A, Nichols MD, Jensen JT. Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial. Contraception. 2003 Jan; 67(1): 9-13.
25. Legro RS, Pauli JG, Kunselman AR, Meadows JW, KesnerJS, Zaino RJ, et al. Effects of continuous versus cyclical oral contraception: a randomized controlled trial. J. Clin. Endocrinol. Metab. 2008 Feb; 93 (2): 420-9.
26. Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception. 2006 Mar; 73 (3): 229-34.
27. Kroll R, Reape KZ, Margolis M. The efficacy and safety of a low-dose, 91-day, extendedregimen oral contraceptive with continuous ethinyl estradiol. Contraception. 2010 Jan; 81 (l):41-8.
28. Lete I, DovalJL, Perez-Campos E, Lertxundi R, Correa M, de la Viuda E, et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception. 2008 Apr; 77 (4): 276-82.
29. Aubeny E, Buhler M, Colau JC, Vicaut E, Zadikian M, Childs M. Oral contraception: patterns of non-compliance. The Coraliance study. Eur. J. Contracept. Reprod. Health Care. 2002 Sep; 7 (3): 155-61.
30. Potter L, Oakley D, de Leon-Wong E, CanamarR. Measuring compliance among oral contraceptive users. Fam. Plann. Per-spect. 1996; 28 (4): 154-8.
31. Flou MY, Flurwitz S, Kavanagh E, Fortin J, Goldberg AB. Using daily text-message reminders to improve adherence with oral contraceptives: a randomized controlled trial. Obstet. Gynecol. 2010 Sep; 116 (3): 633-40.
32. Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud. Fam. Plann. 2014 Sep; 45 (3): 301-14.
33. Rosenberg MJ, Waugh MS, Meehan ТЕ. Use and misuse of oral contraceptives: risk indicators for poor pill taking and discontinuation. Contraception. 1995 May; 51 (5):283-8.
34. Zapata LB, Steenland MW, Brahmi D, Marchbanks PA, Curtis KM. Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review. Contraception. 2013 May; 87 (5): 685-700.
35. Elliesen J, Trümmer D. Adherence to a flexible extended regimen for oral hormonal contraception provided in blister packaging compared with an adherence-supporting digital tablet dispenser: historical comparison of data from two clinical studies. Int. J. Womens Health. 2016; 8: 351-6.
36. Nappi RE, Kaunitz AM, BitzerJ. Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians. Eur. J. Contracept. Reprod. Health Care. 2016; 21 (2): 106-15.
Review
For citations:
Kuznetsova I.V., Burchakov D.I. Menstrual cycle management: new concept for use of combined oral contraceptives. Medical alphabet. 2017;2(10):40-47. (In Russ.)
Views:
312
Email this article 